Generative AI has become a crucial tool in drug discovery, significantly accelerating the identification of new therapeutics. AI systems, trained with data on target engagement and pharmacological properties, can rapidly generate new therapeutic candidates, reducing R&D timelines by years. Several AI-assisted drugs are already in clinical trials. Like any pharmaceutical, AI-assisted therapeutics require patent protection.…